Lataa...
In vivo pharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria
OBJECTIVES: Cefepime/taniborbactam is a cephalosporin/cyclic boronate β-lactamase inhibitor combination under development for the treatment of infections due to MDR Enterobacterales and Pseudomonas aeruginosa. Using a neutropenic murine thigh infection model, we aimed to determine the pharmacokineti...
Tallennettuna:
| Julkaisussa: | J Antimicrob Chemother |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7662185/ https://ncbi.nlm.nih.gov/pubmed/32862218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa373 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|